Hepion Pharmaceuticals (HEPA) 10-Q2022 Q1 Quarterly report

Filed: 16 May 22, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: absolute, Accelerated, accuracy, adequate, aforementioned, alcohol, altering, attract, automatically, CFO, choose, consumption, criteria, damage, defending, Deposit, depositing, detect, detected, devoted, die, distribution, eligibility, encounter, endothelial, error, eventually, expedited, expend, facilitate, Fast, formation, formulation, fraud, frequent, fully, futility, genetic, gradual, halting, hand, IIb, immune, infrastructure, intellectual, intervention, IPO, jointly, leverage, main, matter, medical, medication, microenvironment, mortality, network, neural, opportunity, pan, portfolio, preceded, prevent, Priority, proceed, prosecuting, published, pursue, pursued, quality, recurrence, refine, Rencofilstat, retain, role, scarring, scope, spend, stability, staffing, strategic, succeed, summarized, system, thereof, tissue, transformation, twelve, type, unanticipated, unchanged, underscore, understood, unforeseen, unknown, unmet, validly

Removed: Aid, alternative, annum, assessed, assist, assure, attestation, auditor, Bank, burden, CAD, carryback, ceased, Chase, close, closed, collectively, combined, commencing, committed, comparable, comply, conditioned, conducted, consultant, consummate, consummation, continuing, daily, decreased, deductible, deducting, deduction, deferment, delivery, division, documentation, efficiency, eliminate, employer, ensuing, environment, established, exchanged, execution, exercisability, exercisable, federally, fixed, Fordham, forfeiture, free, HCV, HDV, Hedging, hired, implemented, Importantly, improve, improvement, improving, inciting, infrequently, insured, JPMorgan, liquidity, listed, loan, maintained, manner, maximum, observed, occurred, owed, Oxley, par, paragraph, Paycheck, paying, permitted, plain, PPP, Protection, put, qualified, reduction, refundable, relating, Relief, remeasure, remediate, remediating, remediation, reorganization, representative, requirement, resource, resulted, reviewing, rollforward, royalty, SAB, scaled, security, separately, shelf, side, Simplifying, smaller, software, Step, ThinkEquity, timely, Title, trade, trading, transparency, uncapped, underwriting, underwritten, vanilla, vivo

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

HEPA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

HEPION PHARMACEUTICALS, INC.

FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2022

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I am the Chief Executive Officer of Hepion Pharmaceuticals, Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended March 31, 2022 and filed with the Securities and Exchange Commission (“Form 10-Q”).

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 16, 2022			/s/ Robert Foster
			Robert Foster
			Chief Executive Officer and Director
			(Principal Executive Officer)